Submucosal Injectable Composition is designed to be used for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions prior to excision with a snare or other endoscopic device.
The global Submucosal Injectable Composition market was valued at US$ 131 million in 2023 and is anticipated to reach US$ 203.6 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
With the continuous advancement of medical technology, the submucosal injectable composition has emerged as an innovative therapeutic approach gaining attention and traction. Submucosal injection involves the direct administration of drugs or therapeutic substances beneath the mucosal layer, allowing for more precise drug delivery and treatment. This method holds promise across various medical domains, particularly in the realms of gastrointestinal disorders, urological conditions, and more. As the demand for minimally invasive treatments grows, the submucosal injectable composition is poised to become a significant innovation within the medical field, tapping into substantial potential.
This report aims to provide a comprehensive presentation of the global market for Submucosal Injectable Composition, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injectable Composition.
Report Scope
The Submucosal Injectable Composition market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Submucosal Injectable Composition market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injectable Composition manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
The Standard
EndoClot Plus
GI Supply
Cosmo Pharmaceuticals
Ovesco
Seikagaku
Segment by Type
Prefilled Syringes
Vial
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Submucosal Injectable Composition manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Submucosal Injectable Composition in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Submucosal Injectable Composition Market Overview
1.1 Product Overview and Scope of Submucosal Injectable Composition
1.2 Submucosal Injectable Composition Segment by Type
1.2.1 Global Submucosal Injectable Composition Market Value Comparison by Type (2024-2030)
1.2.2 Prefilled Syringes
1.2.3 Vial
1.3 Submucosal Injectable Composition Segment by Application
1.3.1 Global Submucosal Injectable Composition Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Submucosal Injectable Composition Market Size Estimates and Forecasts
1.4.1 Global Submucosal Injectable Composition Revenue 2019-2030
1.4.2 Global Submucosal Injectable Composition Sales 2019-2030
1.4.3 Global Submucosal Injectable Composition Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Submucosal Injectable Composition Market Competition by Manufacturers
2.1 Global Submucosal Injectable Composition Sales Market Share by Manufacturers (2019-2024)
2.2 Global Submucosal Injectable Composition Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Submucosal Injectable Composition Average Price by Manufacturers (2019-2024)
2.4 Global Submucosal Injectable Composition Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Submucosal Injectable Composition, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Submucosal Injectable Composition, Product Type & Application
2.7 Submucosal Injectable Composition Market Competitive Situation and Trends
2.7.1 Submucosal Injectable Composition Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Submucosal Injectable Composition Players Market Share by Revenue
2.7.3 Global Submucosal Injectable Composition Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Submucosal Injectable Composition Retrospective Market Scenario by Region
3.1 Global Submucosal Injectable Composition Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Submucosal Injectable Composition Global Submucosal Injectable Composition Sales by Region: 2019-2030
3.2.1 Global Submucosal Injectable Composition Sales by Region: 2019-2024
3.2.2 Global Submucosal Injectable Composition Sales by Region: 2025-2030
3.3 Global Submucosal Injectable Composition Global Submucosal Injectable Composition Revenue by Region: 2019-2030
3.3.1 Global Submucosal Injectable Composition Revenue by Region: 2019-2024
3.3.2 Global Submucosal Injectable Composition Revenue by Region: 2025-2030
3.4 North America Submucosal Injectable Composition Market Facts & Figures by Country
3.4.1 North America Submucosal Injectable Composition Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Submucosal Injectable Composition Sales by Country (2019-2030)
3.4.3 North America Submucosal Injectable Composition Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Submucosal Injectable Composition Market Facts & Figures by Country
3.5.1 Europe Submucosal Injectable Composition Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Submucosal Injectable Composition Sales by Country (2019-2030)
3.5.3 Europe Submucosal Injectable Composition Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Submucosal Injectable Composition Market Facts & Figures by Country
3.6.1 Asia Pacific Submucosal Injectable Composition Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Submucosal Injectable Composition Sales by Country (2019-2030)
3.6.3 Asia Pacific Submucosal Injectable Composition Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Submucosal Injectable Composition Market Facts & Figures by Country
3.7.1 Latin America Submucosal Injectable Composition Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Submucosal Injectable Composition Sales by Country (2019-2030)
3.7.3 Latin America Submucosal Injectable Composition Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Submucosal Injectable Composition Market Facts & Figures by Country
3.8.1 Middle East and Africa Submucosal Injectable Composition Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Submucosal Injectable Composition Sales by Country (2019-2030)
3.8.3 Middle East and Africa Submucosal Injectable Composition Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Submucosal Injectable Composition Sales by Type (2019-2030)
4.1.1 Global Submucosal Injectable Composition Sales by Type (2019-2024)
4.1.2 Global Submucosal Injectable Composition Sales by Type (2025-2030)
4.1.3 Global Submucosal Injectable Composition Sales Market Share by Type (2019-2030)
4.2 Global Submucosal Injectable Composition Revenue by Type (2019-2030)
4.2.1 Global Submucosal Injectable Composition Revenue by Type (2019-2024)
4.2.2 Global Submucosal Injectable Composition Revenue by Type (2025-2030)
4.2.3 Global Submucosal Injectable Composition Revenue Market Share by Type (2019-2030)
4.3 Global Submucosal Injectable Composition Price by Type (2019-2030)
5 Segment by Application
5.1 Global Submucosal Injectable Composition Sales by Application (2019-2030)
5.1.1 Global Submucosal Injectable Composition Sales by Application (2019-2024)
5.1.2 Global Submucosal Injectable Composition Sales by Application (2025-2030)
5.1.3 Global Submucosal Injectable Composition Sales Market Share by Application (2019-2030)
5.2 Global Submucosal Injectable Composition Revenue by Application (2019-2030)
5.2.1 Global Submucosal Injectable Composition Revenue by Application (2019-2024)
5.2.2 Global Submucosal Injectable Composition Revenue by Application (2025-2030)
5.2.3 Global Submucosal Injectable Composition Revenue Market Share by Application (2019-2030)
5.3 Global Submucosal Injectable Composition Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Submucosal Injectable Composition Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 The Standard
6.2.1 The Standard Corporation Information
6.2.2 The Standard Description and Business Overview
6.2.3 The Standard Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.2.4 The Standard Submucosal Injectable Composition Product Portfolio
6.2.5 The Standard Recent Developments/Updates
6.3 EndoClot Plus
6.3.1 EndoClot Plus Corporation Information
6.3.2 EndoClot Plus Description and Business Overview
6.3.3 EndoClot Plus Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.3.4 EndoClot Plus Submucosal Injectable Composition Product Portfolio
6.3.5 EndoClot Plus Recent Developments/Updates
6.4 GI Supply
6.4.1 GI Supply Corporation Information
6.4.2 GI Supply Description and Business Overview
6.4.3 GI Supply Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GI Supply Submucosal Injectable Composition Product Portfolio
6.4.5 GI Supply Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Corporation Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cosmo Pharmaceuticals Submucosal Injectable Composition Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Ovesco
6.6.1 Ovesco Corporation Information
6.6.2 Ovesco Description and Business Overview
6.6.3 Ovesco Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ovesco Submucosal Injectable Composition Product Portfolio
6.6.5 Ovesco Recent Developments/Updates
6.7 Seikagaku
6.6.1 Seikagaku Corporation Information
6.6.2 Seikagaku Description and Business Overview
6.6.3 Seikagaku Submucosal Injectable Composition Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Seikagaku Submucosal Injectable Composition Product Portfolio
6.7.5 Seikagaku Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Submucosal Injectable Composition Industry Chain Analysis
7.2 Submucosal Injectable Composition Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Submucosal Injectable Composition Production Mode & Process
7.4 Submucosal Injectable Composition Sales and Marketing
7.4.1 Submucosal Injectable Composition Sales Channels
7.4.2 Submucosal Injectable Composition Distributors
7.5 Submucosal Injectable Composition Customers
8 Submucosal Injectable Composition Market Dynamics
8.1 Submucosal Injectable Composition Industry Trends
8.2 Submucosal Injectable Composition Market Drivers
8.3 Submucosal Injectable Composition Market Challenges
8.4 Submucosal Injectable Composition Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Boston Scientific
The Standard
EndoClot Plus
GI Supply
Cosmo Pharmaceuticals
Ovesco
Seikagaku
*If Applicable.